Cotter Aine, Jinih Marcel
Royal College of Surgeons, Dublin, Ireland.
Discov Oncol. 2025 Jul 1;16(1):1188. doi: 10.1007/s12672-025-02588-y.
There is ongoing uncertainty about the association between thyroid nodule size and likelihood of malignancy. Researchers are divided, some proposing that risk is increased with nodule size while others claim the opposite. Numerous studies have been completed but there is at present no agreed consensus. Furthermore, the diagnostic accuracy of fine needle aspiration (FNA), the standard test for investigating thyroid nodules is disputed. Reported ranges of false negatives range from 2 to 20%.
The overall aims of this study were to investigate the relationship between thyroid nodule size and malignancy and to examine the association between FNA results and malignancy rates in small and large nodules.
Systematic review and meta-analysis of observational studies examining the association between malignancy and thyroid nodule size.
A systematic review was completed using search words 'thyroid, nodule and size' in PubMed database. Criteria for inclusion were retrospective or prospective studies with nodule size and final pathology and/or FNA results that had a primary focus on adult populations.
In total 17 studies were deemed eligible for inclusion. 16 studies were included in the first meta-analysis looking at the relationship between nodule size and malignancy rates. Overall, nodules over 4 cm were associated with a lower incidence of malignancy, 15% compared with 37%. A Random effects model meta-analysis was undertaken, which also indicated a trend towards a lower risk of malignancy in nodules over 4 cm, with a risk difference of 0.1 (95% CI - 0.01, 0.21). However, there was significant heterogeneity with an Iof 99%, therefore caution has to be exercised when interpreting the results. 11 studies were included in the second meta- analysis, examining the impact of nodule size on the association between FNA results and malignancy. The meta-analysis showed that there was no statistically difference between the false negative rates of nodules less than or greater than 4 cm.
While there is a trend towards larger nodule being less likely to indicate malignancy, thyroid nodule size does not appear to have a significant influence on the accuracy of FNA in predicting cancer. Thyroid nodule size alone should not influence the decision to refer for further tests or surgery as it is an unreliable predictor of malignancy in isolation. However, taken in conjunction with clinical and radiological findings it may be a useful adjunct to guiding treatment.
甲状腺结节大小与恶性可能性之间的关联一直存在不确定性。研究人员存在分歧,一些人认为风险随结节大小增加,而另一些人则持相反观点。已经完成了大量研究,但目前尚无共识。此外,细针穿刺抽吸活检(FNA)作为研究甲状腺结节的标准检查,其诊断准确性也存在争议。报道的假阴性率范围为2%至20%。
本研究的总体目的是调查甲状腺结节大小与恶性之间的关系,并检查FNA结果与大小结节恶性率之间的关联。
对观察性研究进行系统评价和荟萃分析,以检查恶性与甲状腺结节大小之间的关联。
在PubMed数据库中使用搜索词 “甲状腺、结节和大小” 完成了系统评价。纳入标准为回顾性或前瞻性研究,其结节大小、最终病理和 / 或FNA结果主要针对成年人群。
总共17项研究被认为符合纳入条件。16项研究被纳入第一项荟萃分析,以研究结节大小与恶性率之间的关系。总体而言,直径超过4厘米的结节恶性发生率较低,分别为15%和37%。进行了随机效应模型荟萃分析,结果也表明直径超过4厘米的结节恶性风险有降低趋势,风险差异为0.1(95%CI -0.01,0.21)。然而,异质性显著,I²为99%,因此在解释结果时必须谨慎。11项研究被纳入第二项荟萃分析,研究结节大小对FNA结果与恶性之间关联的影响。荟萃分析表明,直径小于或大于4厘米的结节假阴性率在统计学上没有差异。
虽然有大结节恶性可能性较小的趋势,但甲状腺结节大小似乎对FNA预测癌症的准确性没有显著影响。仅甲状腺结节大小不应影响进一步检查或手术的决定,因为它单独作为恶性的预测指标并不可靠。然而,结合临床和影像学检查结果,它可能是指导治疗的有用辅助手段。